Helminths: New Insights from Immunity to Global Health
Organizer(s): De' Broski Herbert, P'ng Loke, Nicola L. Harris and Frank Brombacher Date: December 08 - 12, 2019
Location: Southern Sun Cape Sun, Cape Town, Western Cape, South Africa
For important information on the coronavirus, please click here
Parasitic worms, or helminths, infect roughly one in five people on the planet and cause pathology in hundreds of millions. Given the global impact on human health and welfare, there is a great need to develop novel therapies and/or vaccines that target helminths. In addition, the unique nature of how these parasites interact with their hosts has brought tremendous insight into the mammalian immune system. Experimental studies of helminth infection have led to the identification of new cell types involved in type 2 immunity, including innate lymphoid cells, tuft cells, and new roles for neurons, in addition to revealing novel pathways of tissue repair and immune-modulation. The interactions of helminths with the microbiome has also come to light in recent years. This conference will highlight some of the most impactful advances in the fields of helminth genomics, helminth biology, vaccine design and host protective immunity, in addition to new discoveries highlighting the ability of these organisms to modulate the immune system, human disease and the microbiome.
Global Health Travel Award Deadline: July 9 2019
Scholarship Deadline: August 8 2019
Discounted Abstract Deadline: August 8 2019
Abstract Deadline: September 24 2019
Discounted Registration Deadline: October 10 2019
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email firstname.lastname@example.org if you are interested.
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI147679-01
Funding for this conference was made possible (in part) by 1R13AI147679-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. This award is co-funded by National Center for Advancing Translational Sciences (NCATS) and the National Institute of Allergy and Infectious Diseases.